Results 191 to 200 of about 43,749 (262)

Discontinuation of Heart Failure Pharmacotherapy in Older Adults With Frailty. [PDF]

J Am Heart Assoc
Nakamaru R, Nishimura S, Kumamaru H, Daigo K, Walsh KM, Kohsaka S.   +5 more
europepmc   +1 more source

Clinical risk factors of licorice-induced pseudohyperaldosteronism: a 2026-updated narrative review. [PDF]

Front Pharmacol
Yoshino T, Makino T.
europepmc   +1 more source

Is Obesity a Major Driver of Primary Aldosteronism? [PDF]

JACC Basic Transl Sci
Hall JE, Omoto ACM, Hall ME.
europepmc   +1 more source

Concurrence of the Core Mechanistic Tenets of the American Heart Association Statement on the Cardiovascular-Kidney-Metabolic Syndrome and the Adipokine Hypothesis of Heart Failure With Preserved Ejection Fraction. [PDF]

Diabetes Obes Metab
Packer M.
europepmc   +1 more source

Finerenone Utilization for Chronic Kidney Disease and Diabetes: Multicenter Real-World Study in the United States. [PDF]

JACC Adv
Lin W, Schweber A, Xu Y, Chang AR, Farag YM, Mukhopadhyay A, Blecker SB, Horwitz LI, Grams ME, Shin JI.   +9 more
europepmc   +1 more source

Heart Failure Trajectories After Guideline-Directed Medical Therapy.

JAMA Netw Open
Do D, Murugiah K, Sawano M, Goodwin Cartwright BM, Gratzl S, Curtis LH, Stucky NL.   +6 more
europepmc   +1 more source